Nuveen’s Alkermes ALKS Stock Holding History

Nuveen’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-10,000	Closed	-$586K	–	1587
2014 Q4	$586K	Buy	+10,000	New	+$509K	﹤0.01%	1343

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Nuveen's ALKS Position: Q1 2026 in Review

Nuveen increased its Alkermes (ALKS) stake by 1.4% in Q1 2026, buying an estimated $1.04M and bringing the position to 2,460,569 shares worth $87M. The position accounts for 0.02% of the portfolio, ranked #436.

Nuveen first reported a position in ALKS in Q2 2013 and has held it in 52 quarters since. 389 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

Nuveen held 2,460,569 shares of Alkermes worth $87M as of Q1 2026.
Nuveen bought 33,541 Alkermes shares in Q1 2026, an estimated $1.04M.
Alkermes made up 0.02% of Nuveen's portfolio in Q1 2026, its #436 holding.
Nuveen first reported a position in Alkermes in Q2 2013 and has held it in 52 quarters since.
389 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.